GlassScriptPhysician profile
Brian P Butler
NPI 1093758195
$10,029.88
in general payments reported to CMS, 2019-2025
44 companies · $1,575 in 2025
The $1,575 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,961 · 2020: $2,135 · 2021: $1,150 · 2022: $1,034 · 2023: $1,377 · 2024: $798 · 2025: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,347 · Travel and Lodging: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,347.43 |
| Travel and Lodging | $402.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,194.19 | 2020-2025 | Lynparza |
| Neotract INC. | $2,058.10 | 2019-2020 | |
| Astellas Pharma US INC | $857.53 | 2019-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $824.81 | 2025 | |
| Teleflex LLC | $771.39 | 2021-2025 | Urolift, Deknatel |
| Janssen Biotech, INC. | $414.06 | 2021-2025 | Erleada |
| Calyxo, INC. | $320.76 | 2025 | Cvac Aspiration System |
| Intuitive Surgical, INC. | $264.41 | 2022-2024 | |
| Urogen Pharma, INC. | $262.41 | 2020-2024 | Jelmyto |
| Edap Technomed INC | $231.23 | 2023 | |
| Merck Sharp & Dohme LLC | $192.75 | 2023-2025 | Keytruda, Lynparza |
| Abbvie INC. | $169.57 | 2019-2024 | |
| Progenics Pharmaceuticals, INC. | $166.83 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $166.44 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $146.91 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.